Byondis intends to bag commercialisation partner for breast cancer ADC by 2H21

Tulip
Byondis is working with the CRO Syneos Health to manage the Phase III SYD985 trial dubbed TULIP. Credit: Nico De Pasquale Photography via Getty Images